BOGLE INVESTMENT MANAGEMENT L P /DE/ - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 90 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2017. The put-call ratio across all filers is 15.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q2 2020$455,000
-87.7%
4,452
-87.0%
0.08%
-80.3%
Q1 2020$3,689,000
-12.5%
34,178
-5.6%
0.39%
-2.0%
Q4 2019$4,214,000
+251.8%
36,205
+178.7%
0.39%
+380.5%
Q3 2017$1,198,00012,9890.08%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q4 2017
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 149,457$11,773,0006.29%
INDUS CAPITAL PARTNERS, LLC 330,339$26,021,0002.54%
Perpetual Ltd 129,799$10,215,0001.32%
Black Creek Investment Management Inc. 396,525$31,234,0001.18%
RUDMAN ERROL M 28,701$2,261,0001.10%
COMGEST GLOBAL INVESTORS S.A.S. 635,752$50,078,0001.09%
Antipodean Advisors LLC 15,000$1,182,0000.96%
Hillhouse Capital Management 618,391$48,711,0000.83%
JUPITER ASSET MANAGEMENT LTD 215,866$17,004,0000.49%
Temasek Holdings (Private) Ltd 990,000$77,982,0000.48%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders